Precision treatment of colorectal cancer with rare gene mutations / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 669-672, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-872570
ABSTRACT
Colorectal cancer is the most common gastrointestinal malignant tumor. Advances of targeted therapy and immunotherapy have significantly improved the prognosis of patients with colorectal cancer. In recent years, with the concept of precision medicine, molecular classification of colorectal cancer based on molecular pathology has been widely accepted. Patients with BRAF, HER2, MET, PIK3CA, MEK, BRAC1, BRAC2 and other rare driver gene mutations have been gradually paid attention. This article reviews the treatment advances in colorectal cancer with rare driver gene mutations.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS